Daniel Rea

Publications

  1. Published

    The MAGIC survey in hormone receptor positive (HR+), HER2-negative (HER2−) breast cancer: When might multigene assays be of value?

    Daniel Rea, , , , , , , , , , , , , & , 1 Jun 2017, In: The Breast. 33, p. 191-199 9 p.

    Research output: Contribution to journalArticlepeer-review

  2. Published

    Role of Tyrosine Kinase Inhibitors in Lung Cancer

    Daniel Palmer, Daniel Rea & Syed Hussain, 1 Jun 2009, In: Anti-Cancer Agents in Medicinal Chemistry. 9, 5, p. 569-575 7 p.

    Research output: Contribution to journalArticle

  3. Published

    Chemotherapy for advanced colorectal cancer

    Daniel Rea, 1 Jan 2003, In: Colonews. 1, p. 3-6 4 p.

    Research output: Contribution to journalArticle

  4. Published
  5. Published
  6. Published
  7. Published
  8. Published
  9. Published

    Selecting Breast Cancer Patients for Chemotherapy: The Opening of the UK OPTIMA Trial

    Daniel Rea & 2 others, & , 1 Feb 2013, In: Clinical Oncology. 25, 2, p. 109-116 8 p.

    Research output: Contribution to journalArticlepeer-review

  10. E-pub ahead of print

    Comparative survival analysis of multiparametric tests-when molecular tests disagree-A TEAM Pathology study

    Daniel Rea, Dec 2021, In: Breast Cancer. 7, 1, 13 p., 90.

    Research output: Contribution to journalArticlepeer-review

  11. Published
  12. Published
  13. Published

    Do type 1 receptor tyrosine kinases inform treatment choice? A prospectively planned analysis of the TEAM trial

    Daniel Rea, 29 Oct 2013, In: British Journal of Cancer. 109, 9, p. 2453-2461 9 p.

    Research output: Contribution to journalArticlepeer-review

  14. Published
  15. Published
  16. Published
  17. Published
  18. Published

    Predicting anthracycline benefit: TOP2A and CEP17 - Not only but also

    Daniel Rea, , & , 20 May 2015, In: Journal of Clinical Oncology. 33, 15, p. 1680-1687 8 p.

    Research output: Contribution to journalArticlepeer-review

  19. Published
  20. Published

    Molecular stratification of early breast cancer identifies drug targets to drive stratified medicine

    Toon Brookes, , , , , , , Daniel Rea, & , 2017, In: Breast Cancer. 3, p. 3

    Research output: Contribution to journalArticlepeer-review

  21. Published

    Metastatic breast cancer response after exemestane withdrawal: A case report

    Daniel Rea, 1 Jan 2004, In: The Breast. 13, p. 66-68 3 p.

    Research output: Contribution to journalArticle

  22. Published

    Modified de Gramont with oxaliplatin in the first-line treatment of advanced colorectal cancer

    Daniel Rea, , , , , , , , , , , , & , 6 Oct 2003, In: British Journal of Cancer. 89, 7, p. 1155-1158 4 p.

    Research output: Contribution to journalArticle

  23. Published

    Comparison of quadrant-specific breast cancer incidence trends in the United States and England between 1975 and 2013

    Daniel Rea, & , 1 Oct 2016, In: Cancer Epidemiology. 44, p. 186-194 9 p.

    Research output: Contribution to journalArticlepeer-review

  24. E-pub ahead of print

    Valuing preferences for treating screen detected ductal carcinoma in situ

    Hannah Bromley, , , , Daniel Rea & Tracy Roberts, 2 Nov 2019, (E-pub ahead of print) In: European Journal of Cancer. 123, p. 130-137 8 p.

    Research output: Contribution to journalArticlepeer-review

  25. Published
  26. Published

    Coagulopathic complications in breast cancer

    Paul Stonelake, Daniel Rea & Gregory Lip, 15 Oct 2003, In: Cancer. 98, p. 1578-1586 9 p.

    Research output: Contribution to journalArticle

  27. Published
  28. Published

    The Breast Cancer Trainees Research Collaborative Group: A New Multidisciplinary Network to Facilitate Breast Cancer Research

    Daniel Rea & , Jan 2020, In: Clinical Oncology. 32, 1, p. e16-e18 3 p.

    Research output: Contribution to journalEditorialpeer-review

  29. Published
  30. Published

    Perspectives on the future of bisphosphonate use in breast cancer patients

    Daniel Rea, 1 Jan 2004, In: Seminars in Oncology. 31, p. 87-91 5 p.

    Research output: Contribution to journalArticle

  31. Published
  32. Published

    Antibacterial prophylaxis after chemotherapy for solid tumours and lymphomas

    Neil Steven, Lucinda Billingham, , , , , Daniel Rea, , , & , 8 Sep 2005, In: New England Journal of Medicine. 353, 10, p. 988-998 11 p.

    Research output: Contribution to journalArticle

  33. Published
  34. E-pub ahead of print

    Adjuvant tamoxifen and exemestane in postmenopausal early breast cancer: ten-year analysis of the randomised phase III TEAM trial

    Daniel Rea, , , , , & , 18 Jul 2017, (E-pub ahead of print) In: The Lancet Oncology.

    Research output: Contribution to journalArticlepeer-review

  35. Published

    Impact of age on breast cancer mortality and competing causes of death at 10 years follow-up in the adjuvant TEAM trial

    Daniel Rea, , , , , & , 1 Aug 2018, In: European Journal of Cancer . 99, p. 1-8 8 p.

    Research output: Contribution to journalArticlepeer-review

  36. Published
  37. Published
  38. Published
  39. E-pub ahead of print

    Optimising the Duration of Adjuvant Trastuzumab in Early Breast Cancer in the UK

    Daniel Rea, , , , , , , , , , , , & , 25 Jul 2020, (E-pub ahead of print) In: Clinical Oncology.

    Research output: Contribution to journalArticlepeer-review

  40. Published
  41. Published
  42. E-pub ahead of print
  43. Published

    Low grade Ductal Carcinoma in situ (DCIS): how best to describe it?

    Daniel Rea, 1 Oct 2014, In: The Breast. 23, 5, p. 693-696 4 p.

    Research output: Contribution to journalArticlepeer-review

  44. Published
  45. Published

    Reply to K.I. Pritchard

    Daniel Rea, & , 10 Dec 2013, In: Journal of Clinical Oncology. 31, 35, p. 4477-4479 3 p.

    Research output: Contribution to journalArticlepeer-review

  46. Published
  47. Published

    Addressing overtreatment of screen detected DCIS; the LORIS trial

    Toon Brookes, Tracy Roberts, Sarah Pirrie, Lucinda Billingham & 2 others, Sarah Bowden & Daniel Rea, Nov 2015, In: European Journal of Cancer. 51, 16, p. 2296-2303 8 p.

    Research output: Contribution to journalArticlepeer-review

  48. Published

    Viewpoint: Availability of oestrogen receptor and HER2 status for the breast multidisciplinary meeting discussion; time to get it right

    Daniel Rea, , , , , , & , 1 Jul 2016, In: European Journal of Surgical Oncology. 42, 7, p. 994-998 5 p.

    Research output: Contribution to journalArticlepeer-review

  49. Published

    The LORIS Trial: Addressing Overtreatment of Ductal Carcinoma In Situ

    Daniel Rea, 1 Jan 2015, In: Clinical Oncology. 27, 1, p. 6-8

    Research output: Contribution to journalEditorialpeer-review

  50. E-pub ahead of print

    Effect of metformin versus placebo on metabolic factors in the MA.32 randomized breast cancer trial

    & 2 others, Daniel Rea & , Dec 2021, In: Breast Cancer. 7, 1, 8 p., 74.

    Research output: Contribution to journalArticlepeer-review

Previous 1 2 3 Next